Cerner Co. (NASDAQ:CERN) VP Michael R. Battaglioli sold 4,000 shares of the company’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $69.89, for a total transaction of $279,560.00. Following the sale, the vice president now directly owns 4,000 shares of the company’s stock, valued at $279,560. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Cerner Co. (NASDAQ CERN) traded up $0.23 during trading hours on Wednesday, reaching $70.36. 958,300 shares of the company traded hands, compared to its average volume of 2,358,070. The firm has a market cap of $23,312.26, a PE ratio of 31.03, a P/E/G ratio of 2.26 and a beta of 0.94. Cerner Co. has a 1 year low of $47.01 and a 1 year high of $73.86. The company has a current ratio of 2.77, a quick ratio of 2.75 and a debt-to-equity ratio of 0.11.
Cerner (NASDAQ:CERN) last released its earnings results on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.62 by ($0.01). The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. Cerner’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.59 earnings per share. research analysts forecast that Cerner Co. will post 2.25 EPS for the current fiscal year.
Several research firms recently issued reports on CERN. Royal Bank of Canada reaffirmed a “buy” rating on shares of Cerner in a report on Wednesday, October 25th. Jefferies Group reaffirmed a “buy” rating on shares of Cerner in a report on Sunday, October 29th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $70.00 price objective on shares of Cerner in a report on Thursday, November 30th. Zacks Investment Research downgraded shares of Cerner from a “buy” rating to a “sell” rating in a report on Tuesday, October 31st. Finally, Leerink Swann reaffirmed a “hold” rating on shares of Cerner in a report on Saturday, November 25th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and nine have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $69.50.
WARNING: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/12/13/cerner-co-cern-vp-sells-279560-00-in-stock.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.